Wegovy®
A weekly GLP-1 treatment proven to reduce hunger and support meaningful, long-term fat loss.
- ~16.9% average body weight loss
 - Boosts metabolic & cardiovascular health
 - Proven, long-established safety profile
 - Weekly injection, easy to use
 

Saxenda (liraglutide 3.0 mg) is a GLP-1 receptor agonist licensed for weight management in adults with obesity or overweight with weight-related comorbidities. Whilst Saxenda cause leg swelling is a concern raised by some patients, peripheral oedema is not listed as an established adverse reaction in the Summary of Product Characteristics. Leg swelling during Saxenda treatment may arise from multiple causes, including dietary changes, underlying cardiovascular or renal conditions, concurrent medications, or increased physical activity. This article examines the evidence, potential mechanisms, warning signs requiring medical attention, and practical management strategies for patients experiencing leg swelling whilst taking Saxenda.
Summary: Peripheral oedema (leg swelling) is not listed as an established adverse reaction to Saxenda in the Summary of Product Characteristics, and published data do not demonstrate a direct causal association.
Saxenda (liraglutide 3.0 mg) is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed by the MHRA for weight management in adults with obesity or overweight with weight-related comorbidities, and in adolescents aged 12 years and above with obesity.
Peripheral oedema (leg swelling) is not listed as an adverse reaction in the Saxenda Summary of Product Characteristics (SmPC); published data do not demonstrate a causal association, though individual idiosyncratic reactions can occur.
The most frequently reported adverse effects of Saxenda include gastrointestinal symptoms such as nausea, vomiting, diarrhoea, and constipation, which affect a significant proportion of users. The SmPC also notes risks of dehydration and acute kidney injury, which could potentially contribute to fluid balance changes.
It is important to recognise that leg swelling can arise from multiple causes, and its occurrence during Saxenda treatment does not necessarily indicate a direct causal relationship. Factors such as dietary changes, increased physical activity, underlying cardiovascular or renal conditions, or concurrent medications may contribute to fluid retention. If you notice new or worsening leg swelling whilst taking Saxenda, it is essential to discuss this with your GP or prescribing clinician to determine the underlying cause and appropriate management strategy.
Understanding the potential mechanisms by which leg swelling might occur during Saxenda treatment requires consideration of both theoretical factors and broader physiological changes associated with weight management.
Fluid and Electrolyte Changes
Saxenda works by mimicking the action of GLP-1, a naturally occurring hormone that regulates appetite and glucose metabolism. The primary mechanism does not directly affect fluid balance. However, changes in dietary intake, particularly sodium consumption, may influence fluid retention. Patients beginning weight management programmes often alter their eating patterns significantly, which can temporarily affect electrolyte balance and fluid distribution in the body.
Gastrointestinal Effects and Hydration
Saxenda commonly causes gastrointestinal side effects such as nausea, vomiting and diarrhoea. The SmPC notes that these can lead to dehydration and, in some cases, acute kidney injury. Changes in kidney function could potentially affect fluid balance and manifest as oedema in some individuals.
Cardiovascular Considerations
People with pre-existing cardiovascular conditions may be more susceptible to fluid retention from various causes. Those with underlying cardiac conditions should be monitored carefully during any weight management programme.
Increased Mobility and Activity
Patients who increase their physical activity levels as part of a weight management programme may initially experience mild leg swelling due to increased blood flow to the lower limbs and temporary inflammation in muscles and joints unaccustomed to exercise. This type of swelling is generally mild, bilateral, and improves with rest and elevation.
It is worth noting that these mechanisms represent theoretical considerations rather than established causal pathways, as robust evidence linking Saxenda directly to peripheral oedema remains limited.

Whilst mild, transient swelling may not always indicate a serious problem, certain features warrant prompt medical assessment. Recognising warning signs is crucial for patient safety and appropriate clinical management.
Urgent Medical Attention Required
You should seek immediate medical attention if leg swelling is accompanied by:
Chest pain, breathlessness, or difficulty breathing – call 999 or attend A&E immediately as these may indicate heart failure or pulmonary embolism
Sudden onset of severe, unilateral leg swelling with pain – contact NHS 111 or seek same-day GP assessment as this could suggest deep vein thrombosis (DVT)
Swelling of the face, lips, or tongue – call 999 as these are potential signs of a serious allergic reaction (angioedema)
Rapid weight gain (more than 2 kg in a few days) – may indicate significant fluid retention requiring urgent assessment
Reduced urine output or dark urine – possible kidney dysfunction requiring prompt medical attention
Hot, red, tender skin with fever – may indicate cellulitis requiring urgent antibiotic treatment
Non-Urgent GP Consultation
Contact your GP within a few days if you experience:
Persistent or worsening leg swelling that does not improve with rest and elevation
Swelling accompanied by skin changes, such as redness, warmth, or discolouration
New swelling that develops after starting Saxenda, particularly if bilateral and progressive
Swelling associated with other new symptoms such as fatigue, palpitations, or abdominal distension
Your GP will conduct a thorough assessment, including examination and potentially blood tests or imaging, to determine the underlying cause and whether Saxenda should be continued, adjusted, or discontinued. Never stop prescribed medication without medical advice, as abrupt cessation may affect your weight management progress and metabolic control.
If you suspect your leg swelling may be related to Saxenda, you can report this as a suspected side effect via the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk or via the Yellow Card app).
If you experience mild leg swelling whilst taking Saxenda and your clinician has excluded serious underlying causes, several practical measures may help manage symptoms and improve comfort.
Lifestyle Modifications
Elevation and rest: Elevate your legs above heart level for 15–30 minutes several times daily to promote venous return and reduce fluid accumulation. This is particularly helpful in the evening after prolonged standing or sitting.
Compression hosiery: Graduated compression stockings (class 1 or 2) may help prevent fluid pooling in the lower legs, particularly if you spend long periods standing or sitting. Important: Do not use compression stockings if DVT is suspected, if you have peripheral arterial disease, severe neuropathy, or leg ulcers. Seek advice from a healthcare professional for assessment and correct sizing.
Regular movement: Avoid prolonged immobility. If your occupation involves extended sitting or standing, take regular breaks to walk and perform ankle exercises (flexing and pointing the feet) to activate the calf muscle pump.
Dietary Considerations
Sodium intake: Excessive salt consumption promotes fluid retention. Aim to limit processed foods and avoid adding salt to meals. The NHS recommends no more than 6 grams of salt daily for adults.
Adequate hydration: Maintaining good hydration helps the kidneys regulate fluid balance effectively. Aim for 1.5–2 litres of water daily, but follow your clinician's guidance, especially if you have heart failure or kidney disease, as fluid requirements may differ.
Monitoring and Communication
Keep a symptom diary noting when swelling occurs, its severity, and any associated factors. This information helps your healthcare team assess patterns and determine whether the swelling relates to Saxenda or other causes.
Consider discussing a medication review with your GP or pharmacist, as some commonly prescribed medications (such as calcium channel blockers, NSAIDs, corticosteroids) can contribute to leg swelling. Regular follow-up appointments are essential for monitoring your response to treatment and adjusting management as needed.
Leg swelling is a common symptom with numerous potential causes, many of which are unrelated to Saxenda. A comprehensive assessment should consider alternative explanations, particularly in patients with risk factors or comorbidities.
Cardiovascular Causes
Heart failure: Reduced cardiac output leads to fluid accumulation, typically causing bilateral leg swelling that worsens throughout the day. Associated symptoms may include breathlessness, fatigue, and reduced exercise tolerance.
Venous insufficiency: Incompetent valves in leg veins impair blood return to the heart, causing chronic swelling, aching, and skin changes. This condition is more common in older adults and those with a history of DVT.
Deep vein thrombosis (DVT): Blood clot in a deep vein, typically causing unilateral leg swelling with pain, warmth, and redness. Requires urgent assessment as per NICE guidance (NG158).
Renal and Hepatic Conditions
Kidney disease can impair fluid and electrolyte regulation, leading to generalised oedema including leg swelling. Liver disease, particularly cirrhosis, reduces albumin production, decreasing oncotic pressure and promoting fluid accumulation in tissues.
Medications
Several commonly prescribed medications can cause leg swelling, including:
Calcium channel blockers (e.g., amlodipine) for hypertension
Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen
Corticosteroids for inflammatory conditions
Certain diabetes medications, including thiazolidinediones
If you take multiple medications, discuss with your GP whether any could contribute to swelling.
Other Considerations
Lymphoedema: Impaired lymphatic drainage causes progressive, often unilateral swelling. Pregnancy: Hormonal changes and increased blood volume commonly cause leg swelling. Prolonged immobility: Long-distance travel or bed rest can lead to temporary fluid accumulation. Hypothyroidism: Underactive thyroid can contribute to generalised oedema. Cellulitis: Bacterial skin infection causing hot, red, tender swelling requiring antibiotics.
NICE Clinical Knowledge Summary on peripheral oedema emphasises the importance of systematic evaluation to ensure timely diagnosis and treatment of potentially serious conditions. A thorough clinical assessment, including medical history, examination, and appropriate investigations such as blood tests, echocardiography, or venous Doppler ultrasound, helps identify the underlying cause and guide appropriate management.
Peripheral oedema (leg swelling) is not listed as an adverse reaction in the Saxenda Summary of Product Characteristics, and published data do not demonstrate a direct causal association, though individual idiosyncratic reactions can occur.
Seek immediate medical attention if leg swelling is accompanied by chest pain, breathlessness, sudden severe unilateral swelling with pain, facial or tongue swelling, rapid weight gain exceeding 2 kg in a few days, reduced urine output, or hot, red, tender skin with fever.
Alternative causes include heart failure, venous insufficiency, deep vein thrombosis, kidney or liver disease, medications such as calcium channel blockers or NSAIDs, lymphoedema, prolonged immobility, hypothyroidism, and cellulitis. A thorough clinical assessment is essential to identify the underlying cause.
The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.
The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Block quote
Ordered list
Unordered list
Bold text
Emphasis
Superscript
Subscript